Intravascular source of adenosine during forearm ischemia in humans: Implications for reactive hyperemia

Hypertension

Volumn 33, Issue 6, 1999, Pages 1453-1457

  Costa, Fernando ^a   Sulur, Paulgun ^a   Angel, Mark ^a   Cavalcante, José ^a   Haile, Virginia ^a   Christman, Brian ^a   Biaggioni, Italo ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Adenosine; Ischemia; Microdialysis; Muscle

Indexed keywords

ADENOSINE; CAFFEINE; THROMBOXANE B2;

ADULT; ARM BLOOD FLOW; ARM MUSCLE; ARTICLE; FEMALE; FOREARM; HUMAN; HYPEREMIA; ISCHEMIA; MALE; MICRODIALYSIS; MUSCLE LEVEL; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032978992     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.6.1453     Document Type: Article

References (27)

1. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res. 1980;47:807-813.
2. Dobson JGJr, Rubio R, Berne RM. Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res. 1971;29:375-384.
3. Belloni FL, Phair RD, Sparks HV. The role of adenosine in prolonged vasodilation following flow-restricted exercise of canine skeletal muscle. Circ Res. 1979;44:759-766.
4. Metting PJ, Weldy DL, Ronau TF, Britton SL. Effect of aminophylline on hindlimb blood flow autoregulation during increased metabolism in dogs. J Appl Physiol. 1986;60:1857-1864.
5. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989;256:C799-C806.
6. Nees S, Herzog V, Becker BF, Bock M, Des Rosiers C, Gerlach E. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol. 1985;80:515-529.
7. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther. 1991; 258:588-593.
8. Costa F, Biaggioni I. Role of nitric oxide in adenosine-induced vasodilation in humans. Hypertension. 1998;31:1061-1064.
9. Jackson EK, Ohnishi A. Development and application of a simple microassay for adenosine in rat plasma. Hypertension. 1987;10:189-197.
10. Christman BW, Lefferts PL, Blair IA, Snapper JR. Effect of plateletactivating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep. Am Rev Respir Dis. 1990;142:1272-1278.
11. Ballard HJ. The influence of lactic acid on adenosine release from skeletal muscle in anesthetized dogs. J Physiol. 1991;433:95-108.
12. Berne RM, Rubio R, Curnish RR. Release of adenosine from ischemic brain: effect of cerebral vascular resistance and incorporation into cerebral adenosine nucleotides. Circ Res. 1974;35:262-271.
13. Decking UK, Schlieper G, Kroll K, Schrader J. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res. 1997;81:154-164.
14. Costa F, Davis SN, Biaggioni I. Interstitial adenosine concentrations correlate with sympathetic activation induced by ischemic exercise in humans. Circulation. 1997;96:I-364.
15. Zhang J, Wells JN. Effects of chronic caffeine administration on peripheral adenosine receptors. J Pharmacol Exp Ther. 1990;254:270-276.
16. Green RM, Stiles GL. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J Clin Invest. 1986;77:222-227.
17. Fredholm BB. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand. 1982;115:283-286.
18. Gerlach E, Becker BF, Nees S. Formation of adenosine by vascular endothelium: a homeostatic and antithrombogenic mechanism? In: Gerlach E, Becker BF, eds. Topics and perspectives in adenosine research. Berlin, Germany: Springer-Verlag; 1987:309-320.
19. Maekawa K, Saito D, Obayashi N, Uchida S, Haraoka S. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol. 1994;267:H166-H173.
20. Zanzinger J, Bassenge E. Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril. Eur Heart J. 1993;14:164-168.
21. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 1995;92:2135-2141.
22. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92:320-326.
23. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. J Am Coll Cardiol. 1996;27:304-310.
24. Headrick JP, Berne RM. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol. 1990;259: H62-H67.
25. Costa F, Biaggioni I. Role of adenosine in the sympathetic activation produced by isometric exercise in humans. J Clin Invest. 1994;93: 1354-1660.
26. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res. 1985;57:461-469.
27. Kurz MA, Bullough DA, Bugge CJL, Mullane KM, Young MA. Cardio-protection with a novel adenosine regulating agent mediated by intravascular adenosine. Eur J Pharmacol. 1997;322:211-220.